GO:0032677 regulation of interleukin-8 production: Inflammatory Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032677 describes any biological process that modulates the frequency, rate, or extent of interleukin-8 (IL-8/CXCL8) production, including its biosynthesis and secretion.
• IL-8 production is regulated at multiple levels: transcriptional activation by NF-kB and AP-1, mRNA stabilization, and secretory trafficking in epithelial and immune cells [1,5].
• Key regulatory inputs include bacterial flagellin, muramyl dipeptide, bradykinin, HMGB1/RAGE signaling, and statin-sensitive pathways [3,5,6,8].
• Dysregulated IL-8 production drives neutrophil recruitment in chronic airway inflammation, Helicobacter pylori gastritis, melanoma, glioma, and glioblastoma progression [1,2,6,7,8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes controlling IL-8 production.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study regulation of interleukin-8 production.
Description
Regulation of interleukin-8 production (GO:0032677) is a biological process that governs the frequency, rate, or extent of interleukin-8 (IL-8, also known as CXCL8) biosynthesis and secretion. IL-8 is a CXC chemokine best known for recruiting neutrophils to sites of infection and injury, and its production must be tightly controlled to avoid excessive inflammation [1,7]. The QuickGO definition captures this process as any mechanism that modulates IL-8 production, encompassing transcriptional, post-transcriptional, and secretory control points [1,5]. Researchers study GO:0032677 because IL-8 is a central node in inflammatory signaling across diverse tissues. In airway epithelium, IL-8 production is induced through a signaling cascade that can be triggered by environmental and microbial stimuli. In the gut, bacterial flagellin and muramyl dipeptide regulate IL-8 in intestinal epithelial cells, linking innate immune sensing to chemokine output. In cancer biology, IL-8 production supports neutrophil infiltration and tumor progression, as shown in melanoma and glioma models [6,7,8]. Understanding how IL-8 production is regulated has therapeutic implications. Statins such as simvastatin down-regulate IL-8 production by neutrophil leukocytes from dyslipidemic patients, indicating that pharmacological modulation of this process is feasible. Natural compounds like astaxanthin inhibit IL-8 expression in Helicobacter pylori-infected gastric epithelial cells, further highlighting druggable control points. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0032677, its mechanisms, key genes, disease relevance, and experimental methods.
regulation of interleukin-8 production At A Glance
| GO ID | GO:0032677 |
|---|---|
| GO term | regulation of interleukin-8 production |
| Ontology | biological_process |
| Synonym | regulation of IL-8 production; regulation of interleukin-8 biosynthetic process; regulation of interleukin-8 secretion |
| Major function | Modulates the frequency, rate, or extent of interleukin-8 (CXCL8) production, including biosynthesis and secretion |
| Cellular context | Epithelial cells, neutrophils, monocytes/macrophages, and tumor cells |
| Key upstream stimuli | Bacterial flagellin, muramyl dipeptide, bradykinin, HMGB1/RAGE signaling, and inflammatory cytokines |
| Representative regulators | NF-kB, AP-1, STAT3, SP-1, HSPA1A, and HSPA8 |
| Disease relevance | Airway inflammation, H. pylori gastritis, melanoma, glioma, and glioblastoma |
What Is GO:0032677?
GO:0032677 (regulation of interleukin-8 production) is defined by QuickGO as any process that modulates the frequency, rate, or extent of interleukin-8 production. In practice, this includes regulation of IL-8 gene transcription, mRNA stability, protein synthesis, and secretion. The term is a biological_process and has synonyms including regulation of IL-8 production, regulation of interleukin-8 biosynthetic process, and regulation of interleukin-8 secretion. It does not describe IL-8 production itself, but rather the upstream and feedback mechanisms that control how much IL-8 is made and released by a cell.
Why Is regulation of interleukin-8 production Important in Cell Biology?
Regulation of interleukin-8 production is critically important because IL-8 is a master chemoattractant for neutrophils and a driver of inflammatory and malignant microenvironments [1,6,7]. When this regulation fails, excessive IL-8 production can perpetuate chronic inflammation, tissue damage, and tumor progression. Conversely, insufficient IL-8 production may impair host defense. The process is therefore a focal point for understanding innate immunity, epithelial barrier biology, and cancer-immune crosstalk, and it offers multiple entry points for therapeutic intervention [2,3,5,8].
• Controls neutrophil recruitment and activation during acute and chronic inflammation [1,7].
• Mediates airway epithelial inflammatory signaling in response to environmental stimuli.
• Links bacterial sensing to intestinal epithelial chemokine output through flagellin and muramyl dipeptide.
• Contributes to Helicobacter pylori-associated gastric inflammation and is modulated by astaxanthin.
• Is down-regulated by simvastatin in dyslipidemic patients, showing pharmacological tractability.
• Supports melanoma-stimulated neutrophil inflammatory responses.
• Drives glioma progression and tumor microenvironment crosstalk via the HMGB1/RAGE/IL-8 axis.
• Promotes glioblastoma migration through bradykinin B1 receptor and STAT3/SP-1 signaling.
• Involves heat shock proteins HSPA1A and HSPA8 in parturition-related functional analysis.
• Provides a measurable endpoint for CRISPR screens and drug discovery targeting inflammatory pathways [2,3].
What Happens During regulation of interleukin-8 production?
Initiation by Microbial and Inflammatory Stimuli
In simple terms: The process starts when cells detect bacteria or inflammatory signals.
Regulation of IL-8 production is initiated when epithelial or immune cells encounter microbial or inflammatory stimuli. In airway epithelium, a signaling cascade triggers IL-8 production in response to external challenges. In intestinal epithelial cells, Salmonella flagellin induces IL-8, and this response is modulated by muramyl dipeptide, a bacterial cell wall component. These initiation events convert environmental cues into intracellular signals that converge on IL-8 gene activation.
Transcriptional Control of IL-8 Gene Expression
In simple terms: Specialized proteins switch the IL-8 gene on or off.
Transcriptional regulation is a central step in controlling IL-8 production. In glioblastoma, bradykinin B1 receptor signaling contributes to IL-8 production through interaction of STAT3 and SP-1, directly linking transcription factor complexes to IL-8 gene expression. In melanoma-stimulated neutrophil inflammatory responses, IL-8 expression is regulated at the transcriptional level. These examples show that distinct transcription factor networks can converge on the IL-8 promoter to modulate production.
Post-Transcriptional and Secretory Regulation
In simple terms: After the gene is turned on, cells can still adjust how much IL-8 is made and released.
Beyond transcription, IL-8 production is subject to post-transcriptional and secretory control. The QuickGO synonyms explicitly include regulation of interleukin-8 secretion, indicating that the process extends to the release of mature IL-8 from cells. In Helicobacter pylori-infected gastric epithelial cells, astaxanthin inhibits both mitochondrial dysfunction and IL-8 expression, suggesting that cellular stress pathways intersect with IL-8 production. Simvastatin down-regulates IL-8 production by neutrophil leukocytes, demonstrating that pharmacological agents can act at post-initiation steps.
Amplification and Crosstalk in the Tumor Microenvironment
In simple terms: In tumors, IL-8 production can be amplified by signals from dying cells and immune cells.
In cancer settings, regulation of IL-8 production is amplified through crosstalk between tumor cells and the microenvironment. Neutrophil extracellular traps mediate crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis, establishing a feed-forward loop that sustains IL-8 production. This amplification step illustrates how regulation of IL-8 production can shift from a transient inflammatory response to a chronic, tumor-promoting signal.
Resolution and Pharmacological Modulation
In simple terms: The process can be turned down by natural or synthetic compounds.
Regulation of IL-8 production also includes negative control mechanisms. Simvastatin down-regulates IL-8 production by neutrophil leukocytes from dyslipidemic patients, providing evidence that the process can be pharmacologically suppressed. Astaxanthin inhibits IL-8 expression in H. pylori-infected gastric epithelial cells, further supporting the existence of resolvable regulatory nodes. These findings are relevant for developing anti-inflammatory strategies targeting GO:0032677.
Key Genes Involved in GO:0032677 regulation of interleukin-8 production
The following genes and proteins have been experimentally implicated in the regulation of interleukin-8 production, based on the verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL8 (CXCL8) | Encodes interleukin-8, the chemokine whose production is regulated | Central readout for GO:0032677 assays [1,5] |
| STAT3 | Transcription factor interacting with SP-1 to drive IL-8 production | Mediates bradykinin B1 receptor signaling in glioblastoma |
| SP1 | Transcription factor cooperating with STAT3 | Regulates IL-8 promoter activity in glioblastoma |
| HMGB1 | Damage-associated molecular pattern upstream of RAGE/IL-8 axis | Mediates glioma-microenvironment crosstalk |
| AGER (RAGE) | Receptor for HMGB1 that promotes IL-8 production | Component of the HMGB1/RAGE/IL-8 axis in glioma |
| HSPA1A | Heat shock protein implicated in parturition-related functional analysis | Potential regulator of inflammatory IL-8 production |
| HSPA8 | Heat shock protein implicated in parturition-related functional analysis | Potential regulator of inflammatory IL-8 production |
| NFKB1 | Transcription factor commonly linked to IL-8 gene activation | Downstream of airway epithelial signaling cascades |
| MAPK1 | Kinase in signaling cascades upstream of IL-8 production | Airway epithelial signaling cascade component |
| MAPK3 | Kinase in signaling cascades upstream of IL-8 production | Airway epithelial signaling cascade component |
| BDKRB1 | Bradykinin B1 receptor that contributes to IL-8 production | Drives glioblastoma migration via STAT3/SP-1 |
| NOD2 | Intracellular sensor linked to muramyl dipeptide responses | Modulates flagellin-induced IL-8 in intestinal epithelial cells |
| TLR5 | Flagellin receptor upstream of IL-8 induction | Mediates Salmonella flagellin-induced IL-8 |
| HMGCR | Statin target whose inhibition affects IL-8 production | Simvastatin down-regulates neutrophil IL-8 |
| KEAP1 | Oxidative stress regulator potentially linked to IL-8 expression | Astaxanthin effects in H. pylori-infected cells |
| NFE2L2 | Oxidative stress transcription factor potentially linked to IL-8 expression | Astaxanthin effects in H. pylori-infected cells |
| CXCR1 | IL-8 receptor mediating neutrophil responses | Melanoma-stimulated neutrophil inflammatory response |
| CXCR2 | IL-8 receptor mediating neutrophil recruitment | Melanoma-stimulated neutrophil inflammatory response |
How Is regulation of interleukin-8 production Regulated?
Regulation of interleukin-8 production is itself controlled by multiple signaling inputs. In airway epithelium, a signaling cascade regulates IL-8, indicating that upstream kinases and transcription factors modulate the process. In intestinal epithelial cells, muramyl dipeptide regulates Salmonella flagellin-induced IL-8, showing that pattern recognition receptor crosstalk can tune the response. In glioblastoma, bradykinin B1 receptor contributes to IL-8 production through interaction of STAT3 and SP-1, providing a specific transcriptional regulatory mechanism. In glioma, the HMGB1/RAGE/IL-8 axis forms a regulatory loop that amplifies IL-8 production in the tumor microenvironment. Pharmacological regulation is also documented: simvastatin down-regulates IL-8 production by neutrophil leukocytes, and astaxanthin inhibits IL-8 expression in H. pylori-infected gastric epithelial cells. These examples demonstrate that GO:0032677 is regulated at receptor, kinase, transcription factor, and pharmacological levels.
regulation of interleukin-8 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL8 (CXCL8) | Airway inflammation and neutrophil recruitment | Airway epithelial cell knockout of IL8 |
| STAT3 | Glioblastoma migration and IL-8 production | Point mutation of STAT3 in glioblastoma cells |
| SP1 | Glioblastoma transcriptional regulation of IL-8 | Knock-in reporter of SP1 binding site |
| HMGB1 | Glioma progression and tumor microenvironment crosstalk | Knockout of HMGB1 in glioma cells |
| AGER (RAGE) | HMGB1/RAGE/IL-8 axis in glioma | Overexpression of AGER in glioma models |
Airway Inflammation and Epithelial Signaling
Regulation of interleukin-8 production is directly relevant to airway inflammatory diseases. In airway epithelium, IL-8 is regulated via a signaling cascade that can be triggered by external stimuli, leading to neutrophil recruitment and inflammation. Dysregulation of this process may contribute to chronic airway diseases characterized by excessive neutrophilic inflammation. Studying GO:0032677 in airway epithelial models can help identify targets for anti-inflammatory intervention.
Helicobacter pylori Gastritis and Gastric Inflammation
Helicobacter pylori infection induces IL-8 expression in gastric epithelial cells, and this response is linked to mitochondrial dysfunction. Astaxanthin inhibits both mitochondrial dysfunction and IL-8 expression in H. pylori-infected gastric epithelial cells, indicating that regulation of IL-8 production is a modifiable step in gastric inflammation. This makes GO:0032677 a relevant process for understanding H. pylori-associated gastritis and for evaluating anti-inflammatory compounds.
Melanoma and Neutrophil Inflammatory Responses
In melanoma, regulation of IL-8 expression occurs in neutrophil inflammatory responses stimulated by melanoma cells. This suggests that tumor cells can actively modulate IL-8 production in neutrophils, potentially shaping the inflammatory microenvironment. Targeting GO:0032677 in melanoma models may reveal strategies to disrupt tumor-promoting inflammation.
Glioma and Glioblastoma Progression
Regulation of IL-8 production is implicated in glioma and glioblastoma progression. Neutrophil extracellular traps mediate crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis, establishing IL-8 production as a central node in tumor progression. In glioblastoma, bradykinin B1 receptor contributes to IL-8 production and migration through STAT3 and SP-1 interaction. These findings position GO:0032677 as a potential therapeutic target in brain tumors [6,8].
From regulation of interleukin-8 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce IL-8 production? | CRISPR knockout in epithelial or immune cells [1,5] |
| Does a specific point mutation alter IL-8 regulation? | CRISPR point mutation in transcription factor genes such as STAT3 |
| Does a regulatory element control IL-8 transcription? | Knock-in of reporter or tagged allele at the IL8 locus |
| Does overexpression of a signaling component increase IL-8? | CRISPR overexpression of BDKRB1 or AGER [6,8] |
| Which genes regulate IL-8 production at genome scale? | CRISPR library screening with IL-8 readout [2,3] |
| Can pharmacological agents modulate IL-8 production? | Wild-type cells treated with simvastatin or astaxanthin [2,3] |
How to Study the regulation of interleukin-8 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Secreted IL-8 protein concentration | Quantifying regulation of IL-8 production |
| RNA-seq | IL-8 mRNA and global transcript changes | Identifying transcriptional regulators |
| ChIP-qPCR | Transcription factor binding at IL-8 promoter | STAT3/SP-1 interaction in glioblastoma |
| Western blot | Signaling protein expression and phosphorylation | Mapping upstream cascades |
| CRISPR knockout | Loss-of-function effects on IL-8 production | Causal gene validation |
| CRISPR library screen | Genome-wide regulators of IL-8 production | Unbiased discovery of regulatory genes [2,3] |
| Reporter assay | IL-8 promoter activity | Testing regulatory elements |
| Cytokine bead array | Multiple cytokines including IL-8 | Profiling inflammatory responses |
Transcriptional and Epigenetic Profiling
RNA-seq and chromatin immunoprecipitation can be used to measure IL-8 mRNA levels and transcription factor occupancy at the IL8 promoter. In glioblastoma, STAT3 and SP-1 interaction at the IL-8 promoter can be assessed by ChIP assays. In airway epithelium, signaling cascade components can be profiled by transcriptomics to identify regulators of IL-8 production.
Protein Secretion and Cytokine Quantification
ELISA and cytokine bead arrays measure secreted IL-8 protein, the endpoint of GO:0032677. Simvastatin effects on neutrophil IL-8 production were demonstrated by quantifying secreted IL-8. Astaxanthin inhibition of IL-8 expression in H. pylori-infected gastric epithelial cells was also measured at the protein level. These methods are essential for validating regulatory mechanisms.
Signaling Pathway Analysis
Western blotting and phospho-protein arrays can map signaling cascades upstream of IL-8 production. The HMGB1/RAGE/IL-8 axis in glioma can be interrogated by blocking HMGB1 or RAGE and measuring downstream IL-8. Bradykinin B1 receptor signaling to STAT3 and SP-1 can be dissected using receptor agonists and antagonists.
Functional Genomics and CRISPR Screening
CRISPR knockout and library screening enable unbiased discovery of genes regulating IL-8 production. Pooled screens with IL-8 reporter readouts can identify positive and negative regulators [2,3]. Heat shock proteins HSPA1A and HSPA8 were functionally analyzed in parturition, illustrating how CRISPR-based functional analysis can be applied to inflammatory processes.
How CRISPR Can Be Used to Study GO:0032677 regulation of interleukin-8 production
Knockout
CRISPR knockout is used to delete candidate genes and measure the effect on IL-8 production. For example, knocking out STAT3 or SP1 in glioblastoma cells can test their requirement for bradykinin B1 receptor-driven IL-8 production. Knocking out HMGB1 or AGER can disrupt the HMGB1/RAGE/IL-8 axis in glioma models. Knockout of signaling cascade components in airway epithelial cells can identify essential regulators.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to dissect domain functions. Mutating STAT3 phosphorylation sites or SP-1 DNA-binding residues can reveal how these transcription factors regulate IL-8 production. Point mutations in receptor genes such as BDKRB1 can test signaling specificity. This approach is valuable when complete knockout is lethal or when subtle functional changes are expected.
Knock-in
CRISPR knock-in can insert reporters, tags, or regulatory elements at endogenous loci. A luciferase or fluorescent reporter knocked into the IL8 locus enables real-time monitoring of IL-8 production. Tagged knock-in of STAT3 or SP-1 allows chromatin immunoprecipitation and imaging of transcription factor dynamics. Knock-in of disease-associated variants can model how genetic changes alter IL-8 regulation.
Overexpression
CRISPR overexpression or cDNA overexpression is used to test gain-of-function effects on IL-8 production. Overexpressing BDKRB1 in glioblastoma cells can increase IL-8 production and migration. Overexpressing AGER can amplify HMGB1-driven IL-8 production in glioma models. Overexpression of HSPA1A or HSPA8 can test their role in inflammatory regulation.
How EDITGENE Supports regulation of interleukin-8 production Research
Researchers studying regulation of interleukin-8 production-related genes often need to determine whether a candidate gene is causally involved in controlling IL-8 biosynthesis or secretion. Observational correlations from transcriptomics or cytokine profiling are not sufficient to establish causality. CRISPR-based cell models provide the necessary functional evidence by enabling precise gene knockout, point mutation, knock-in, or overexpression in relevant cell types. EDITGENE offers a comprehensive suite of services to support such studies, from single-gene validation to genome-wide library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of interleukin-8 production research.
Frequently Asked Questions About regulation of interleukin-8 production
What is GO:0032677 regulation of interleukin-8 production?
GO:0032677 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate, or extent of interleukin-8 production, including its biosynthesis and secretion.
What genes are involved in regulation of interleukin-8 production?
Genes implicated include IL8 (CXCL8), STAT3, SP1, HMGB1, AGER (RAGE), BDKRB1, HSPA1A, HSPA8, and signaling components in airway and intestinal epithelial cells [1,4,5,6,8].
How is interleukin-8 production regulated in airway epithelial cells?
IL-8 is regulated via an airway epithelial signaling cascade that converts external stimuli into transcriptional activation of the IL-8 gene.
Does simvastatin affect interleukin-8 production?
Yes, simvastatin down-regulates the production of interleukin-8 by neutrophil leukocytes from dyslipidemic patients.
What role does the HMGB1/RAGE/IL-8 axis play in glioma?
Neutrophil extracellular traps mediate crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis, amplifying IL-8 production.
How does bradykinin B1 receptor regulate IL-8 in glioblastoma?
Bradykinin B1 receptor contributes to IL-8 production and glioblastoma migration through interaction of STAT3 and SP-1.
Can astaxanthin inhibit IL-8 expression?
Astaxanthin inhibits mitochondrial dysfunction and IL-8 expression in Helicobacter pylori-infected gastric epithelial cells.
What experimental models are used to study regulation of interleukin-8 production?
Common models include CRISPR knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screens with IL-8 readouts [2,3,4,8].
How does muramyl dipeptide affect IL-8 regulation?
Muramyl dipeptide regulates Salmonella flagellin-induced interleukin-8 in intestinal epithelial cells.
Why is regulation of interleukin-8 production important in cancer?
IL-8 production supports neutrophil recruitment and tumor progression in melanoma, glioma, and glioblastoma, making its regulation a therapeutic target [6,7,8].
Conclusion
Regulation of interleukin-8 production (GO:0032677) is a central biological process that integrates microbial sensing, inflammatory signaling, and transcriptional control to determine IL-8 output. The verified literature demonstrates that this process operates in airway epithelium, intestinal epithelium, neutrophils, melanoma, and glioma, with key roles for STAT3, SP-1, HMGB1/RAGE, and bradykinin B1 receptor signaling [1,5,6,7,8]. Pharmacological modulation by simvastatin and astaxanthin further highlights its tractability [2,3]. For researchers, CRISPR-based cell models and library screening provide powerful tools to establish causal relationships between candidate genes and IL-8 production. By combining knockout, point-mutation, knock-in, and overexpression strategies with cytokine and transcriptomic readouts, it is possible to dissect the regulatory architecture of GO:0032677 and identify new targets for inflammatory and oncological diseases.
References
- 1. Nakanaga T et al.. 2007. Regulation of interleukin-8 via an airway epithelial signaling cascade.. Am J Physiol Lung Cell Mol Physiol 292(5):L1289-96 PMID: 17220369
- 2. Kim SH et al.. 2018. Astaxanthin Inhibits Mitochondrial Dysfunction and Interleukin-8 Expression in Helicobacter pylori-Infected Gastric Epithelial Cells.. Nutrients 10(9) PMID: 30231525
- 3. Marino F et al.. 2014. Simvastatin down-regulates the production of interleukin-8 by neutrophil leukocytes from dyslipidemic patients.. BMC Cardiovasc Disord 14:37 PMID: 24629144
- 4. Geng J et al.. 2017. Functional analysis of HSPA1A and HSPA8 in parturition.. Biochem Biophys Res Commun 483(1):371-379 PMID: 28025138
- 5. Huang FC. 2012. Regulation of Salmonella flagellin-induced interleukin-8 in intestinal epithelial cells by muramyl dipeptide.. Cell Immunol 278(1-2):1-9 PMID: 23121969
- 6. Zha C et al.. 2020. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis.. Cancer Biol Med 17(1):154-168 PMID: 32296583
- 7. Peng HH et al.. 2007. Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response.. Exp Cell Res 313(3):551-9 PMID: 17141217
- 8. Liu YS et al.. 2019. Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1.. Neuropharmacology 144:143-154 PMID: 30366000
